drugset / Trial / NCT00034151
Safety and Efficacy of S-8184 in Second Line Treatment of Stage III or IV Ovarian Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
Phase IIA, multicenter, dose escalation study evaluating the safety and efficacy of weekly S-8184 paclitaxel injectable emulsion in second line treatment of patients with stage III or IV platinum resistant ovarian cancer or primary peritoneal carcinoma.
Timeline
- Start
- 2002-03
- Primary completion
- 2007-09
- Completion
- 2007-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | — | — |